<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">64370</article-id><article-id pub-id-type="doi">10.7554/eLife.64370</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-212749"><name><surname>Fazio</surname><given-names>Maurizio</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0083-6601</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213412"><name><surname>van Rooijen</surname><given-names>Ellen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213414"><name><surname>Dang</surname><given-names>Michelle</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213415"><name><surname>van de Hoek</surname><given-names>Glenn</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213418"><name><surname>Ablain</surname><given-names>Julien</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213413"><name><surname>Mito</surname><given-names>Jeffrey K</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-89732"><name><surname>Yang</surname><given-names>Song</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213416"><name><surname>Thomas</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82758"><name><surname>Michael</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213419"><name><surname>Fabo</surname><given-names>Tania</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8987-0672</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213420"><name><surname>Modhurima</surname><given-names>Rodsy</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213417"><name><surname>Pessina</surname><given-names>Patrizia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82751"><name><surname>Kaufman</surname><given-names>Charles K</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3122-1677</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82753"><name><surname>Zhou</surname><given-names>Yi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20435"><name><surname>White</surname><given-names>Richard M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9099-9169</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-3910"><name><surname>Zon</surname><given-names>Leonard I</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0860-926X</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">Stem Cell Program</institution>, <institution>Boston Children's Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Pathology</institution>, <institution>Brigham and Women's Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Stem Cell Program and Hematology/Oncology</institution>, <institution>Boston Children's Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Medicine</institution>, <institution>Washington University School of Medicine</institution>, <addr-line><named-content content-type="city">St. Louis</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Cancer Biology &amp; Genetics Program</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-131284"><name><surname>McArthur</surname><given-names>Grant</given-names></name><role>Reviewing editor</role><aff><institution>Peter MacCallum Cancer Centre</institution>, <country>Australia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>zon@enders.tch.harvard.edu</email> (LZ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>02</day><month>02</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e64370</elocation-id><history><date date-type="received"><day>27</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>01</day><month>02</month><year>2021</year></date></history><permissions><copyright-statement>Â© 2021, Fazio et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Fazio et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-64370-v1.pdf"/><abstract><p>Recent genomic and scRNA-seq analyses of melanoma demonstrated a lack of recurrent genetic drivers of metastasis, while identifying common transcriptional states correlating with invasion or drug resistance. To test whether transcriptional adaptation can drive melanoma progression, we made use of a zebrafish mitfa:<italic>BRAFV600E</italic>;<italic>tp53-/-</italic> model, in which malignant progression is characterized by minimal genetic evolution. We undertook an overexpression-screen of 80 epigenetic/transcriptional regulators and found neural crest-mesenchyme developmental regulator SATB2 to accelerate aggressive melanoma development. Its overexpression induces invadopodia formation and invasion in zebrafish tumors and human melanoma cell lines. SATB2 binds and activates neural crest-regulators, including <italic>pdgfab</italic> and <italic>snai2</italic>. The transcriptional program induced by SATB2 overlaps with known MITF<sup>low</sup>AXL<sup>high</sup> and AQP1<sup>+</sup>NGFR1<sup>high </sup>drug resistant states and functionally drives enhanced tumor propagation and resistance to Vemurafenib <italic>in vivo</italic>. Here we show that melanoma transcriptional rewiring by SATB2 to a neural crest mesenchyme-like program can drive invasion and drug resistance in endogenous tumors.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001645</institution-id><institution>Boehringer Ingelheim Fonds</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Fazio</surname><given-names>Maurizio</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Netherlands Organization for Scientific Research</institution></institution-wrap></funding-source><award-id>Rubico Fellowship</award-id><principal-award-recipient><name><surname>van Rooijen</surname><given-names>Ellen</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Dutch Cancer Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>van Rooijen</surname><given-names>Ellen</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R01 CA103846</award-id><principal-award-recipient><name><surname>Zon</surname><given-names>Leonard I</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005190</institution-id><institution>Melanoma Research Alliance</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Zon</surname><given-names>Leonard I</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009784</institution-id><institution>Starr Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>White</surname><given-names>Richard M</given-names></name><name><surname>Zon</surname><given-names>Leonard I</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>Ellison Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Zon</surname><given-names>Leonard I</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Richard M White, Senior editor, <italic>eLife</italic>.</p></fn><fn fn-type="conflict" id="conf3"><p>Leonard I Zon, LIZ is a founder and stockholder of Fate Therapeutics Inc., Scholar Rock Inc., Camp4 Therapeutics Inc., Amagma Therapeutics Inc., and a scientific advisor for Stemgent..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Zebrafish were maintained under IACUC-approved conditions  (Boston Children's Hospital Institutional Animal Care and Use Committee protocol # 20-10-4253R).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Data sets are deposited to the GEO Gene Expression Omnibus, accession number GSE77923</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Maurizio Fazio</collab><collab>Ellen van Rooijen</collab><collab>Song Yang</collab><collab>Leonard I Zon</collab></person-group><year iso-8601-date="2020">2020</year><source>SATB2 induces transcriptional programs in melanoma that lead to metastatic behavior</source><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77923">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77923</ext-link><comment>NCBI Gene Expression Omnibus, GSE77923</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-64370-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>